New York · 2025 Regular Session · Bill
A 7409: Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 7409 is a bill introduced in the New York House on March 25, 2025. According to its official title, it concerns: Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists. Primary sponsor: Keith Brown (Republican/Conservative/Independence). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.
Sponsors
Sponsors by party (alphabetical): Republican/Conservative/Independence 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Keith Brown | Primary sponsor | Republican/Conservative/Independence | House | 12 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH